MBS Intelligence

Category: Healthcare

Conversations around mental health have significantly evolved over the last decade. Rather than the ‘stiff upper lip’ approach that was the norm in years past,

It is 20 years since one injured runner organised a timed 5k run for 13 friends in South West London, on the condition that they

Who is responsible for people’s health? As rates of ill health in the working population have risen across the world in the aftermath of the

As a sector, Healthcare is built on the strengths and commitment of its clinicians, scientists and carers. Like pilots, engineers, designers, lawyers and teachers, these

Few chief executives spend more than a decade in any individual role: in the FTSE 100, the average tenure is six years, and CEOs in

I’ve been advising organisations in the healthcare sector for more than a decade now, and have always been inspired by the purpose and dedication on

Latest News

Thriva partners with medical device manufacturer, Tasso for ‘needle free’ blood testing. The blood testing company has partnered with Tasso, to offer ‘needle-free’ at-home blood testing. The device aims to make blood testing accessible by attaching to the top of the arm and deploying a lancet into the skin at the press of the button.
Ezra launches AI-powered full body MRI scan in the UK. The healthcare technology company has launched the system which assesses 13 organs and detects over 500 conditions within a single 60-minute session, reducing scan times and enhancing radiology workflows. It plans to roll-out nationwide later this year.
Phantom Neuro secures $19m of funding. The startup, which is developing a wristband-like device that lets a person control prosthetic limbs, has raised the funding for its next stage of development. Participating investors include Breakout Ventures, Draper Associates and Intel.
Pfizer halts development of weight loss drug. The pharmaceutical company will pause development of the weight loss pill after a patient in one of its trials experienced ‘potential drug-induced liver injury’. Pfizer hoped to break into the forecasted $100bn market with this new drug.
Sancell partners with the NHS for skin cancer clinical trials. The life sciences company has partnered with the NHS to do clinical trials of a new vaccine to treat skin cancer. Patients with advanced melanoma will be able to join the study to improve the efficacy of drugs known as immunotherapy.
Cofertility raises $7.25m in funding. The healthcare startup which offers women no-cost egg freezing in exchange for donating half the retrieved eggs to those unable to conceive, has secured funding in a Series A round led by Next Ventures and Offline Ventures. Its total funding is now $16m.

Certification Note

Certified B Corporation” is a trademark licensed by B Lab, a private non-profit organization, to companies like ours that have successfully completed the B Impact Assessment (“BIA”) and therefore meet the requirements set by B Lab for social and environmental performance, accountability, and transparency. It is specified that B Lab is not a conformity assessment body as defined by Regulation (EU) No 765/2008, nor is it a national, European, or international standardization body as per Regulation (EU) No 1025/2012. The criteria of the BIA are distinct and independent from the harmonized standards resulting from ISO norms or other standardization bodies, and they are not ratified by national or European public institutions.